首页 | 本学科首页   官方微博 | 高级检索  
检索        

遗传病二代测序临床检测全流程规范化共识探讨(2)——样品采集处理及检测
引用本文:曾秀凤,许振朋,黄辉,屈武斌,伍建,王娟,高勇,安冬艳,王小清,熊慧,沈亦平,祁鸣心,邓旭旭,许雄,孙乐乐,彭智宇,顾卫红,黄尚志,于世辉.遗传病二代测序临床检测全流程规范化共识探讨(2)——样品采集处理及检测[J].中华医学遗传学杂志,2020(3):339-344.
作者姓名:曾秀凤  许振朋  黄辉  屈武斌  伍建  王娟  高勇  安冬艳  王小清  熊慧  沈亦平  祁鸣心  邓旭旭  许雄  孙乐乐  彭智宇  顾卫红  黄尚志  于世辉
作者单位:明码(上海)生物科技有限公司;深圳华大基因股份有限公司;艾吉泰康生物科技(北京)有限公司;北京迈基诺基因科技股份有限公司;安诺优达基因科技(北京)有限公司;北京希望组生物科技有限公司;北京金准基因科技有限责任公司;上海瀚垚生物医学科技有限公司;厦门基源医学检测有限公司;哈佛医学院波士顿儿童医院;广西妇幼保健院广西儿童医院;浙江大学医学院附属第一医院/邵逸夫医院;浙江迪安诊断技术股份有限公司;罗切斯特大学医学中心;北京贝瑞和康生物技术有限公司;湖南大地同年生物科技有限公司;中文人类表型标准用语联盟;北京协和医学院、世界卫生组织遗传病社区控制合作中心;广州金域医学检验中心有限公司
摘    要:二代测序技术(next generation sequencing,NGS)具有极高的检测通量,相对低的检测成本,高度的准确性(accuracy)和精准性(precision),是遗传病临床检测的有力工具之一。NGS实验室的检测流程是否规范,将直接影响NGS数据的稳定性、可靠性和有效性,将决定其是否能被用于遗传病的临床辅助诊断或筛查。因此.作为遗传病基因检测的重要环节之一,NGS实验室中流程的规范化与标准化非常重要。2019年5月,在第二届基因检测联盟会议上,针对如何规范NGS检测流程,从事遗传病临床诊治、实验室检测以及第三方基因检测机构的专家进行了全面充分的讨论,旨在规范基于NGS的基因检测流程,对检测流程中的前、中、后三个阶段(包括样本采集/接收/保存、NGS建库、上机测序及数据质控)的操作与实施提出了专业性的指导意见,以规范NGS技术在遗传病基因检测领域中的应用。本文根据此次研讨会上各行业专家的讨论,总结并发布NGS实验室检测流程的规范共识,以促进NGS实验室流程的规范化和标准化,推进我国NGS实验室在遗传病基因检测领域的快速和专业化发展。

关 键 词:二代测序  样品采集  建库  数据质控

A consensus on the standardisation of the next generation sequencing process for the diagnosis of genetic diseases(2)-Sample collection,processing and detection
Zeng Xiufeng,Xu Zhenpeng,Huang Hui,Qu Wubin,Wu Jian,Wang Juan,Gao Yang,An Dongyan,Wang Xiaoqing,Xiong Hui,Shen Yiping,Qi Ming,Deng Xuxu,Xu Xiong,Sun Lele,Peng Zhiyu,Gu Weihong,Huang Shangzhi,Yu Shihui.A consensus on the standardisation of the next generation sequencing process for the diagnosis of genetic diseases(2)-Sample collection,processing and detection[J].Chinese Journal of Medical Genetics,2020(3):339-344.
Authors:Zeng Xiufeng  Xu Zhenpeng  Huang Hui  Qu Wubin  Wu Jian  Wang Juan  Gao Yang  An Dongyan  Wang Xiaoqing  Xiong Hui  Shen Yiping  Qi Ming  Deng Xuxu  Xu Xiong  Sun Lele  Peng Zhiyu  Gu Weihong  Huang Shangzhi  Yu Shihui
Institution:(WuXi Next CODE(Shanghai)Biotechnology Co.,Ltd.,Shanghai 200131,China;BGI-Genomics,BGI Shenzhen,Guangdong 518083,China;GenrTrch Bioscience Co.,Ltd.,Beijing 102206,China;MyGenostics Inc,Beijing 101318,China;Annoroad Gene Technology Co.,Ltd.,Beijing 100176,China;Beijing GrandOmics Biotechnology Co.,Ltd.,Beijing 102200,China;Running Gene Inc.,Beijing 100083,China;SierraVast Bio-Medical Technology Co.,Ltd.,Shanghai 201318,China;Genokon Institute of Medical Science and Laboratory Co.,Ltd.,Xiamen,Fujian 360000,China;Boston Children's Hospital,Hamard Medical School,Boston,XIA 02115,USA;Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region,Sunning,Guangxi 530000,China;The First Affiliated Hospital,SRRS Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang 310058,China;Zhejiang DIAN Diagnostics Co.,Ltd.,Hangzhou,Zhejiang 310013,China;University of Rochester Medical Center,New York,NY 14642,USA;Berry Genomics Co.,Ltd.,Beijing 102206,China;YearthBio Co.,Ltd.,Changsha,Hunan 410205,China;The Chinese Human Phenotype Ontology(CHPO)Consortium,Movement Disorder&Neurogenetics Research Center,Department of Neurology,China-Japan Friendship Hospital,Beijing 100029,China;Peking Union Medical College,WHO Collaborating Center for Community Control of Hereditary Diseases,Beijing 100005,China;KingMed Medical Diagnosis Center Co.,Ltd.,Guangzhou,Guangdong 510000,China)
Abstract:With high accuracy and precision,next generation sequencing(NGS)has provided a powerful tool for clinical testing of genetic diseases.To follow a standardized experimental procedure is the prerequisite to obtain stable,reliable,and effective NGS data for the assistance of diagnosis and/or screening of genetic diseases.At a conference of genetic testing industry held in Shanghai.May 2019,physicians engaged in the diagnosis and treatment of genetic diseases,experts engaged in clinical laboratory testing of genetic diseases and experts from third-party genetic testing companies have fully discussed the standardization of NGS procedures for the testing of genetic diseases.Experts from different backgrounds have provided opinions for the operation and implementation of NGS testing procedures including sample collection,reception,preservation,library construction,sequencing and data quality control.Based on the discussion,a consensus on the standardization of the testing procedures in NGS laboratories is developed with the aim to standardize NGS testing and accelerate implementation of NGS in clinical settings across China.
Keywords:Next generation sequencing  Sample collection  Library construction  Data quality control
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号